S.Science Company, Ltd. (5721) AI Stock Analysis

• Market Cap: ¥17.56B
• Dividend Yield: N/A
• Average Volume (3M): 23.67M
• Price to Earnings (P/E): 304.8
• Beta (1Y): 0.60
• Revenue Growth: -24.20%
• EPS Growth: -82.44%
• Country: JP
• Employees: 27
• Sector: Industrials
• Sector Strength: 93
• Industry: Conglomerates
• EPS (TTM): -0.48
• Shares Outstanding: 141,593,750
• 10 Day Avg. Volume: 13,890,919
• 30 Day Avg. Volume: 23,667,743
• PEG Ratio: N/A
• Price to Book (P/B): 5.72
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 22.62K
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 65 Neutral
• Price Target: ―

S.Science Company, Ltd.'s overall score is influenced primarily by strong revenue growth and a solid equity position, though tempered by challenges in profitability and cash flow. Technical indicators suggest some positive momentum, but the high P/E ratio signals potential overvaluation. The absence of earnings call insights or corporate events means there's less immediate context to adjust these views.

S.Science Company, Ltd. Business Overview & Revenue Model

Company Description

S.Science Company, Ltd. (5721) is a dynamic enterprise operating within the industrial and technological sectors. The company specializes in the development and manufacturing of advanced materials and components, providing innovative solutions for a wide range of industries including electronics, automotive, and healthcare. With a strong emphasis on research and development, S.Science Company, Ltd. is committed to delivering high-quality products that meet the evolving needs of its global clientele.

How the Company Makes Money

S.Science Company, Ltd. generates revenue through the sale of its advanced materials and components to various industries. The company's key revenue streams include direct sales to electronics manufacturers, automotive companies, and healthcare providers who utilize its products in their production processes. Additionally, S.Science Company, Ltd. engages in strategic partnerships and collaborations that enhance its market presence and drive sales growth. The company's focus on innovation and R&D allows it to maintain a competitive edge, ensuring a steady demand for its cutting-edge solutions.

S.Science Company, Ltd. Financial Statement Overview

Summary

S.Science Company, Ltd. demonstrates strong revenue growth and a solid equity position, indicating potential for long-term stability. However, profitability and cash flow challenges persist, suggesting a need for improved cost management and operational efficiency to fully capitalize on its growth potential.

Income Statement

The company shows robust revenue growth with a 13.5% increase from the previous year and a consistent upward trend over the past few years. Despite this, profitability metrics such as the gross profit margin (7.8%) and negative EBIT margin indicate challenges in controlling costs. However, the transition from a negative to a positive net income suggests improving profitability.

Balance Sheet

The balance sheet reflects a strong equity position with a high equity ratio of 91.9% and a very low debt-to-equity ratio due to minimal debt levels. Although these are positive signs of stability, the company has faced fluctuations in total liabilities over recent years, which could indicate some risk.

Cash Flow

Cash flow statements show a consistent negative free cash flow, reflecting challenges in generating positive cash flow from operations. However, the free cash flow has shown minor improvements, and the high operating cash flow to net income ratio suggests that the company is converting its income effectively into cash.

Breakdown	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	634.43M	1.54B	1.36B	1.16B	1.08B
Gross Profit	71.83M	119.81M	229.87M	248.73M	180.49M
EBITDA	-89.66M	440.44M	-95.05M	-311.44M	-251.41M
Net Income	-96.11M	426.42M	-105.52M	-329.38M	-269.62M
Balance Sheet
Total Assets	3.01B	3.27B	2.95B	2.94B	2.01B
Cash, Cash Equivalents and Short-Term Investments	2.18B	1.83B	1.31B	1.74B	969.37M
Total Debt	0.00	3.00M	3.00M	3.00M	3.00M
Total Liabilities	135.60M	263.77M	316.80M	250.18M	216.12M
Stockholders Equity	2.87B	3.01B	2.63B	2.69B	1.80B
Cash Flow
Free Cash Flow	-254.29M	-149.97M	-142.79M	-454.46M	-76.13M
Operating Cash Flow	-253.41M	-149.74M	-142.41M	-214.96M	-76.13M
Investing Cash Flow	259.71M	1.09B	-289.19M	-76.69M	-43.81M
Financing Cash Flow	-22.00K	-13.00K	-10.00K	1.22B	2.65M

S.Science Company, Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 119.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5721, the sentiment is Negative. The current price of 119 is below the 20-day moving average (MA) of 142.45, below the 50-day MA of 175.82, and above the 200-day MA of 73.52, indicating a neutral trend. The MACD of -22.53 indicates Positive momentum. The RSI at 39.23 is Neutral, neither overbought nor oversold. The STOCH value of 36.59 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:5721.

S.Science Company, Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
5706	79 Outperform	$336.34B	5.20	20.86%	2.81%	10.15%	148.74%
5703	76 Outperform	€105.91B	8.55	5.42%	4.08%	5.05%	37.05%
Sector *	71 Outperform	¥266.83B	13.99	8.47%	2.88%	6.37%	12.94%
5711	71 Outperform	$302.71B	8.88	5.00%	4.34%	27.35%	14.36%
5721	65 Neutral	¥17.56B	304.82		―	-24.20%	-82.44%
5713	54 Neutral	¥960.05B	58.25	0.90%	3.02%	10.24%	-71.82%
5707	51 Neutral	$10.13B	―	-22.81%	―	-3.47%	96.86%